Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
IEEE Journal of Biomedical and Health Informatics|March 29, 2024
Equivariant Line Graph Neural Network for Protein-Ligand Binding Affinity PredictionYiqiang Yi, Xu Wan, Kangfei Zhao, et al.
Drug Delivery|April 9, 2019
pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancerXu Wan, Chaoqian Liu, Yinan Lin, et al.
Molecular Pharmaceutics|September 30, 2021
<i>In Vivo</i> Delivery of siRNAs Targeting EGFR and BRD4 Expression by Peptide-Modified Redox Responsive PEG-PEI Nanoparticles for the Treatment of Triple-Negative Breast CancerXu Wan, Runzhou Sun, Yun Bao, et al.
Frontiers in Public Health|July 16, 2026
Empowerment model construction and empirical study of community-based recruitment of platelet donorsDanfeng Cheng, Pei Yang, Xu Wan, et al.
Journal of Infection and Public Health|January 23, 2023
Cost-effectiveness of ceftazidime/avibactam plus metronidazole versus meropenem as first-line empiric therapy for the treatment of complicated intra-abdominal infections: A study based on the in-vitro surveillance data in ChinaXiaoping Shi, Jie Fu, Xiaoyu Li, et al.
Journal of Clinical Laboratory Analysis|July 16, 2013
Brief communication: comparison the diagnostic performance of four HBsAg ELISA kitsXu Wan-zhou, Li Yan, Wu Qing, et al.
Pakistan Journal of Pharmaceutical Sciences|January 18, 2022
Complex renal calculi treated with traditional Chinese medicine Paishi decoction combined with laparoscopic ureterectomyCaiying Bao, Tianshu Ni, Sichao Shao, et al.
The Kaohsiung Journal of Medical Sciences|March 8, 2022
Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2Gang Zhang, Song-Lin Liu, Wen-Ting Yi, et al.
International Journal of Pharmaceutics|February 22, 2015
The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancerXu Wan, Xiaoyao Zheng, Xiaoying Pang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2014
The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's diseaseChi Zhang, Xiaoyao Zheng, Xu Wan, et al.
Pageof 5